Navigation Links
NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region
Date:7/22/2009

DUBAI, United Arab Emirates and SAN FRANCISCO, July 22 /PRNewswire/ -- NewBridge Pharmaceuticals, a specialty pharmaceutical, biologics, and medical device company serving the Middle East, Africa, Turkey & Caspian regions, today announced that it has entered into an exclusive license and supply agreement with Axcan Pharma for Pylera(R), an innovative 3-in-1 capsule therapy for the eradication of Helicobacter pylori, a bacterium now recognized as being the main cause of gastric and duodenal ulcers. Pursuant to the agreement, NewBridge is entitled to obtain exclusive rights in certain markets where it obtains required regulatory approvals and launches the product. The product should be launched in Q4 2010.

Pylera(R), which was developed by Axcan over the last ten years, is a patented 3-in-1 capsule therapy. Each Pylera(R) capsule contains bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride. Pylera(R) is clinically proven to be as effective as the most widely prescribed therapeutic regimen for the eradication of Helicobacter pylori (omeprazole, amoxicillin and clarithromycin) and has the potential to be used in a wide range of patients as a first-line therapy for the eradication of Helicobacter pylori based on its convenient 10-day treatment dosing regimen. Pylera(R) provides additional clinical benefit by improving patient compliance. Pylera(R) received FDA approval in September 2006 and was successfully launched in the United States in May 2007.

"In partnering with Axcan for the Pylera 3-in-1 capsule therapy for Helicobacter pylori eradication, NewBridge Pharmaceuticals advances further to become one of the key providers of innovative pharmaceutical care to the Middle East, Turkey, CIS and Africa," said Dr. Garrett Vygantas, CEO of NewBridge Pharmaceuticals. "NewBridge's strategy of providing world-cla
'/>"/>

SOURCE NewBridge Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Newbridge Securities Corporation Forms BioVentures Division
2. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
7. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
8. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
9. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
10. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
11. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ajority Leader Richard Gephardt Brings Together A-...Communities for "Best and Brightest Forum on Medi... Several of New Jersey,s...earch, medicine and technology gathered today at t...e of medical innovation in New Jersey, and through...
(Date:12/1/2009)...la., Dec. 1 Expanding its European...Inc. of Sarasota has appointed Lake Chemicals and ...is located near Birmingham, England. ,, Osprey...ve the agricultural, waste water, and environmenta...to open drain fields, and clean up industrial and ...
(Date:12/1/2009)..., Dec. 1 The Burrill Biotech Selec... it lost in October. The Select,s gain of 4.5 perc...the general markets with the Dow up 6.5 percent an...ld firm in the final two trading days of the month...ing holiday shopping and Dubai,s reported debt woe...
(Date:12/1/2009)... EpiVax, Inc. today announced a collaborative rese...HBY) aimed at evaluating EpiVax’s proprietar...duce detrimental immune responses to certain drugs... the EpiVax Tregitope technology will be evaluated... therapeutics. , (Vocus) ...
Breaking Biology Technology:New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
...lands, June 17 , - Equens and Albert Heijn Develo...ocessor Equens and supermarket chain Albert Heijn,...ngertip. For a period of,six months, customers of ...g using their fingertips. The objective of the pil...ogy as a new payment method and,establish whether ...
...wire/ -- Sinovac Biotech Ltd. (Amex:,SVA), a leadi...that the,Shanxi Center for Disease Control and Pre... the inactivated hepatitis A vaccine manufactured ... 47,000 doses of Bilive(R),a combined hepatitis A ...he,vaccine purchased by the local CDCs will be uti...
...ssen the epidemic of diarrhea-related deaths among...he laboratory of Nobel Laureate Ferid Murad, M.D.,...Center at Houston have discovered a novel compound...reatment. The results of pre-clinical tests appear...ceedings of the National Academy of Sciences of t...
Other Biology Technology:Start of First Fingertip Payment Pilot in the Netherlands 2Start of First Fingertip Payment Pilot in the Netherlands 3Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 2Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 3Novel compound may treat acute diarrhea 2Novel compound may treat acute diarrhea 3Novel compound may treat acute diarrhea 4Novel compound may treat acute diarrhea 5
(Date:12/1/2009)...searchers at the Yerkes National Primate Research ...ted the first transgenic prairie voles, an importa...ir bonding. The future application of this techno...enetic manipulations that will help identify the b...x social behaviors. This advancement may also have...
(Date:12/1/2009)...his release is available in German . , Brown ...t contains loads of mitochondria, miniature power... In doing this, they normally generate a voltage s...nergy for cellular processes. However, the mitocho...y go full steam ahead all the time. The energy rel...
(Date:12/1/2009)... July the scientists, one from the United States, ... Brutus, the leader of his wolf pack, on remote El.... Their goal to finally find out what these "Nort... in one of the harshest areas of the world., "We..." said David Mech, a renowned U.S. Geological Surv...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2Brown fat cells make 'spare tires' shrink 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Lower IQ Linked to Higher Risk of Heart Deaths 51763 1Lower IQ Linked to Higher Risk of Heart Deaths 51763 2Video 3A Sodexo Takes on Childhood Obesity in School Cafeterias 51760 1Video 3A Sodexo Takes on Childhood Obesity in School Cafeterias 51760 2Video 3A Sodexo Takes on Childhood Obesity in School Cafeterias 51760 3Video 3A Sodexo Takes on Childhood Obesity in School Cafeterias 51760 4CSC Signs 24115 Million IT Services Renewal Agreement With Henry Ford Health System 51756 1CSC Signs 24115 Million IT Services Renewal Agreement With Henry Ford Health System 51756 2
...hensive survey of coral biodiversity in Panama,s L...nvironmental Conservation by researchers from the... colleagues, has resulted in clear conservation re... , "To evaluate strategies for the protection of ...e gathered basic information about coral species d...
...HIA Early laboratory research has shown that res...the abnormal cell formation that leads to most typ...or the agent in breast cancer prevention. ,Resvera...red grapes. It is sold in extract form as a dietar...ratrol has the ability to prevent the first step t...
...ry results suggest that patients with aggressive n...t benefit from a modified chemotherapy regimen, re...CLU) organized by the European Society for Medical... Cairo University reports that giving these patien... weeks as usual, improved treatment outcomes. , T...
Other Biology News:Smithsonian coral biodiversity survey of Panama's Pearl Islands 2Smithsonian coral biodiversity survey of Panama's Pearl Islands 3Researchers identify cancer preventive properties in common vitamin supplement 2New treatment approach promising for lymphoma patients in the developing world 2
Normal Donor Donkey Serum - 100mL from GeneTex
Goat Anti-Human PPP2R5B Polyclonal Antibody, Unconjugated from AbD Serotec
Dog Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
acridine orange 10-nonyl bromide (nonyl acridine orange) from Molecular Probes (Invitrogen)
Biology Products: